路 The biotech company Invivyd, which makes the #COVID19 monoclonal antibody Pemgarda, announced that it has launched the SPEAR Study Group to explore the drug for #LongCOVID and post-vaccine syndrome (PVS)
路 A new study from Taiwan published in Pediatrics and Neonatology found about 14% of children developed Long COVID after being infected with #SarsCoV2
路 A new observational study is investigating the relationship between COVID-19 and #Diabetes
https://thesicktimes.org/2025/07/08/research-updates-july-8/